Raphas Co., Ltd. (KOSDAQ: 214260)

Market Cap	123.94B
Revenue (ttm)	28.38B
Net Income (ttm)	-11.44B
Shares Out	8.41M
EPS (ttm)	-1,313.07
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	51,354
Average Volume	36,005
Open	14,860
Previous Close	14,860
Day's Range	14,610 - 15,100
52-Week Range	9,300 - 31,500
Beta	1.42
RSI	42.95
Earnings Date	Mar 14, 2025

About Raphas

Raphas Co., Ltd. provides skin-based drug delivery systems in South Korea, Japan, and China. The company offers cosmetics under the Acropass brand. It also provides original design manufacturer services in producing cosmetics for various needs, such as wrinkle reduction, freckle, and acne treatment; and medical contract manufacturing services. The company was founded in 2006 and is headquartered in Seoul, South Korea.

• Industry: Perfumes, Cosmetics, and Other Toilet Preparations
• Founded: 2006
• Employees: 77
• Stock Exchange: KOSDAQ
• Ticker Symbol: 214260

Financial Performance

In 2023, Raphas's revenue was 27.94 billion, an increase of 18.18% compared to the previous year's 23.64 billion. Losses were -8.80 billion, 3.45% more than in 2022.